Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155
Last updated 2023-03-22
Summary
In AD (Alzheimer disease), the anatomic correlates of attention disorders (as evaluated by motor slowing) have not been thoroughly characterized.
Conditions
- Alzheimer Disease
Interventions
- DEVICE
-
Brain MRI
- OTHER
-
neuropsychological evaluation
- BIOLOGICAL
-
Blood
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Principal Investigators
-
Daniela ANDRIUTA, PhD · CHU Amiens
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-12-01
- Primary Completion
- 2023-12-01
- Completion
- 2023-12-31
Countries
- France
Study Locations
More Related Trials
-
Evaluating Simvastatin's Potential Role in Therapy
NCT00486044 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682 ·Status: COMPLETED
-
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
NCT01265394 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging in Alzheimer's Disease
NCT00039702 ·Status: COMPLETED
-
Vestibular Therapy in Alzheimer's Disease
NCT03799991 ·Status: RECRUITING ·Phase: NA
-
Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients
NCT00842920 ·Status: UNKNOWN ·Phase: PHASE4
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects
NCT00456417 ·Status: COMPLETED ·Phase: PHASE1
-
In Vivo Alzheimer Proteomics
NCT02263235 ·Status: TERMINATED ·Phase: NA
-
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
NCT03721705 ·Status: COMPLETED ·Phase: PHASE3
-
Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment
NCT02007291 ·Status: COMPLETED
-
Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly
NCT00954616 ·Status: COMPLETED
-
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
NCT05801380 ·Status: RECRUITING
-
Effect of Indomethacin on the Progression of Alzheimer's Disease
NCT00432081 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Early Brain Injury Mechanism and Comprehensive Intervention of VCI
NCT04999813 ·Status: UNKNOWN ·Phase: NA
-
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
NCT02931136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
NCT00523666 ·Status: UNKNOWN ·Phase: PHASE4
-
Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
NCT00004557 ·Status: COMPLETED
-
Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research
NCT07152418 ·Status: NOT_YET_RECRUITING
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease
NCT00939822 ·Status: COMPLETED ·Phase: PHASE2